Knowledge Center

Article / Jan 01, 2004

Selecting lactose for a capsule-based dry powder inhaler

Authors:
  • Hartwig Steckel
  • Fadi Eskandar
  • Peter Villax
Source:
Pharmaceutical Technology Europe (2004), 16(4), 23

Dry powder inhalers are a well-accepted dosage form for pulmonary drug delivery and a wide variety are either currently available or development. This article examines a premetered, capsule-based multidose inhaler for which different qualities of _-lactose monohydrate were screened.

Also in the Knowledge Center

Related Content

Continuous Tableting for Drug Product

ËÄÉ«AV´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more

Wet Polishing

This is a proprietary ËÄÉ«AV technology for addressing complex particle reduction challenges.

Page
Read more

What we do

ËÄÉ«AV is a Contract Development and Manufacturing Company dedicated to helping Pharmaceutical Customers bring new and off-patent drugs to market.

Page
Read more